ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 165 filers reported holding ANIKA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,703,662 | +215.0% | 574,539 | +339.3% | 0.01% | +150.0% |
Q2 2023 | $3,397,560 | +1458080.3% | 130,776 | +1511.1% | 0.00% | – |
Q1 2023 | $233 | -93.9% | 8,117 | -93.8% | 0.00% | -100.0% |
Q4 2022 | $3,847 | -98.4% | 129,961 | +1216.9% | 0.00% | – |
Q3 2022 | $235,000 | -71.4% | 9,869 | -73.2% | 0.00% | -100.0% |
Q2 2022 | $823,000 | -24.3% | 36,865 | +21.6% | 0.00% | 0.0% |
Q4 2021 | $1,087,000 | -18.3% | 30,325 | -2.9% | 0.00% | 0.0% |
Q3 2021 | $1,330,000 | -30.9% | 31,244 | -29.7% | 0.00% | 0.0% |
Q2 2021 | $1,924,000 | -61.7% | 44,452 | -64.0% | 0.00% | -75.0% |
Q1 2021 | $5,030,000 | +357.7% | 123,326 | +407.7% | 0.00% | +300.0% |
Q4 2020 | $1,099,000 | -35.8% | 24,290 | -59.0% | 0.00% | -75.0% |
Q1 2020 | $1,713,000 | -65.6% | 59,236 | -38.3% | 0.00% | -33.3% |
Q4 2019 | $4,978,000 | -52.8% | 96,014 | -50.0% | 0.01% | -64.7% |
Q3 2019 | $10,536,000 | -10.2% | 191,961 | -33.5% | 0.02% | -5.6% |
Q2 2019 | $11,732,000 | +71.2% | 288,825 | +27.5% | 0.02% | +80.0% |
Q1 2019 | $6,851,000 | +7.0% | 226,557 | +18.9% | 0.01% | 0.0% |
Q4 2018 | $6,404,000 | +66.6% | 190,548 | +109.0% | 0.01% | +100.0% |
Q3 2018 | $3,845,000 | +88.2% | 91,161 | +42.8% | 0.01% | +66.7% |
Q2 2018 | $2,043,000 | -5.4% | 63,835 | +47.0% | 0.00% | 0.0% |
Q1 2018 | $2,159,000 | +938.0% | 43,415 | +1024.4% | 0.00% | – |
Q4 2017 | $208,000 | -54.3% | 3,861 | -50.8% | 0.00% | -100.0% |
Q3 2017 | $455,000 | -87.9% | 7,843 | -91.0% | 0.00% | -85.7% |
Q1 2017 | $3,775,000 | +112.6% | 86,892 | +139.5% | 0.01% | +75.0% |
Q4 2016 | $1,776,000 | -80.0% | 36,279 | -80.5% | 0.00% | -73.3% |
Q3 2016 | $8,890,000 | +340.5% | 185,788 | +393.8% | 0.02% | +200.0% |
Q2 2016 | $2,018,000 | -25.2% | 37,622 | -37.7% | 0.01% | -28.6% |
Q1 2016 | $2,699,000 | -57.0% | 60,353 | -63.3% | 0.01% | -46.2% |
Q4 2015 | $6,270,000 | -16.6% | 164,309 | -30.4% | 0.01% | -13.3% |
Q3 2015 | $7,515,000 | +83.2% | 236,089 | +90.1% | 0.02% | +87.5% |
Q2 2015 | $4,103,000 | +99.3% | 124,224 | +148.4% | 0.01% | +100.0% |
Q1 2015 | $2,059,000 | -70.3% | 50,000 | -70.6% | 0.00% | -73.3% |
Q4 2014 | $6,930,000 | -49.7% | 170,096 | -54.7% | 0.02% | -57.1% |
Q3 2014 | $13,778,000 | +142.9% | 375,829 | +207.0% | 0.04% | +118.8% |
Q2 2014 | $5,672,000 | +42.0% | 122,424 | +26.0% | 0.02% | +33.3% |
Q1 2014 | $3,993,000 | +323.4% | 97,152 | +293.3% | 0.01% | +300.0% |
Q4 2013 | $943,000 | +246.7% | 24,700 | +117.3% | 0.00% | +200.0% |
Q3 2013 | $272,000 | +23.1% | 11,365 | -12.4% | 0.00% | 0.0% |
Q2 2013 | $221,000 | – | 12,980 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 490,331 | $21,928,000 | 10.27% |
CAPITAL MANAGEMENT CORP /VA | 211,660 | $9,465,000 | 3.66% |
AMI ASSET MANAGEMENT CORP | 336,791 | $15,061,000 | 1.03% |
Baltimore-Washington Financial Advisors, Inc. | 68,785 | $3,076,000 | 0.93% |
Portolan Capital Management | 130,939 | $5,856,000 | 0.78% |
Kalos Management, Inc. | 19,254 | $861,000 | 0.72% |
DIKER MANAGEMENT LLC | 32,965 | $1,474,000 | 0.56% |
THOMPSON SIEGEL & WALMSLEY LLC | 1,526,244 | $68,253,000 | 0.56% |
NEW AMSTERDAM PARTNERS LLC/NY | 108,260 | $4,841,000 | 0.51% |
Boston Trust Walden Corp | 493,780 | $22,082,000 | 0.38% |